Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BCC NYSE:DGX NYSE:DHI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBCCBoise Cascade$72.83-1.9%$76.95$65.14▼$95.55$2.61B1.15373,695 shs412,737 shsDGXQuest Diagnostics$190.84+0.9%$198.21$164.65▼$213.50$20.94B0.61.08 million shs739,938 shsDHID.R. Horton$146.11-2.1%$146.25$114.17▼$184.54$42.30B1.412.62 million shs1.81 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBCCBoise Cascade+2.77%-5.93%+0.55%-16.63%-15.50%DGXQuest Diagnostics-0.94%-0.14%-5.02%-1.55%+7.20%DHID.R. Horton+1.73%-1.62%+5.23%-5.64%+22.35%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBCCBoise Cascade$72.83-1.9%$76.95$65.14▼$95.55$2.61B1.15373,695 shs412,737 shsDGXQuest Diagnostics$190.84+0.9%$198.21$164.65▼$213.50$20.94B0.61.08 million shs739,938 shsDHID.R. Horton$146.11-2.1%$146.25$114.17▼$184.54$42.30B1.412.62 million shs1.81 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBCCBoise Cascade+2.77%-5.93%+0.55%-16.63%-15.50%DGXQuest Diagnostics-0.94%-0.14%-5.02%-1.55%+7.20%DHID.R. Horton+1.73%-1.62%+5.23%-5.64%+22.35%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBCCBoise Cascade 2.50Moderate Buy$98.0034.56% UpsideDGXQuest Diagnostics 2.50Moderate Buy$216.5813.49% UpsideDHID.R. Horton 2.13Hold$168.5415.35% UpsideCurrent Analyst Ratings BreakdownLatest DHI, BCC, and DGX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/6/2026BCCBoise Cascade Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$97.005/6/2026BCCBoise Cascade DA DavidsonSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$95.00 ➝ $92.005/5/2026BCCBoise Cascade DA DavidsonSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$95.005/4/2026BCCBoise Cascade Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D+)5/4/2026DGXQuest Diagnostics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeBuy (B) ➝ Buy (B+)4/24/2026DHID.R. Horton Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C) ➝ Hold (C+)4/23/2026DHID.R. Horton CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$162.00 ➝ $173.004/22/2026DGXQuest Diagnostics UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$210.00 ➝ $220.004/22/2026DGXQuest Diagnostics BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$225.00 ➝ $230.004/22/2026DGXQuest Diagnostics Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$224.00 ➝ $229.004/22/2026DGXQuest Diagnostics Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$220.00 ➝ $225.00(Data available from 5/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBCCBoise Cascade$6.40B0.40$7.96 per share9.15$57.29 per share1.27DGXQuest Diagnostics$11.04B1.91$15.32 per share12.46$69.25 per share2.76DHID.R. Horton$34.25B1.21$12.26 per share11.92$85.33 per share1.71Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBCCBoise Cascade$132.84M$2.9624.6013.441.101.73%5.55%3.46%N/ADGXQuest Diagnostics$992M$9.0521.0916.552.259.07%15.60%7.06%N/ADHID.R. Horton$3.59B$10.6713.6912.292.099.51%12.94%8.93%7/21/2026 (Estimated)Latest DHI, BCC, and DGX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/4/2026Q1 2026BCCBoise Cascade$0.43$0.50+$0.07$0.50$1.46 billion$1.50 billion4/21/2026Q1 2026DGXQuest Diagnostics$2.37$2.50+$0.13$2.24$2.83 billion$2.90 billion4/21/2026Q2 2026DHID.R. Horton$2.15$2.24+$0.09$2.24$7.55 billion$7.56 billion2/10/2026Q4 2025DGXQuest Diagnostics$2.35$2.42+$0.07$2.18$2.75 billion$2.81 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBCCBoise Cascade$0.881.21%-15.53%29.73%6 YearsDGXQuest Diagnostics$3.441.80%+7.34%38.01%14 YearsDHID.R. Horton$1.801.23%+17.98%16.87%10 YearsLatest DHI, BCC, and DGX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/30/2026BCCBoise Cascadequarterly$0.221.11%6/1/20266/1/20266/17/20264/21/2026DHID.R. Hortonquarterly$0.451.23%5/7/20265/7/20265/14/20262/10/2026DGXQuest Diagnosticsquarterly$0.861.73%4/6/20264/6/20264/20/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBCCBoise Cascade0.242.771.74DGXQuest Diagnostics0.671.181.08DHID.R. Horton0.276.460.97Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBCCBoise Cascade96.18%DGXQuest Diagnostics88.06%DHID.R. Horton90.63%Insider OwnershipCompanyInsider OwnershipBCCBoise Cascade1.42%DGXQuest Diagnostics0.88%DHID.R. Horton0.66%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBCCBoise Cascade7,66035.19 million34.69 millionOptionableDGXQuest Diagnostics57,000110.70 million109.72 millionOptionableDHID.R. Horton14,341283.58 million281.71 millionOptionableDHI, BCC, and DGX HeadlinesRecent News About These Companies5 Most Undervalued High Quality Stocks to Buy NowMay 7 at 4:51 PM | insidermonkey.comSwedbank AB Sells 17,034 Shares of D.R. Horton, Inc. $DHIMay 7 at 6:33 AM | marketbeat.comTruist Financial Corp Sells 32,336 Shares of D.R. Horton, Inc. $DHIMay 7 at 5:59 AM | marketbeat.comD.R. Horton, Inc. $DHI Stock Holdings Decreased by Principal Financial Group Inc.May 6 at 6:15 AM | marketbeat.comQRG Capital Management Inc. Trims Stake in D.R. Horton, Inc. $DHIMay 6 at 6:15 AM | marketbeat.comD.R. Horton, Inc. (DHI) Stock ForecastsMay 5 at 6:26 PM | ca.finance.yahoo.comA Look At D.R. Horton (DHI) Valuation After Weaker Fiscal 2026 EarningsMay 5 at 8:22 AM | finance.yahoo.comD.R. Horton, Inc. $DHI Shares Acquired by Strs OhioMay 4 at 6:36 AM | marketbeat.com228,516 Shares in D.R. Horton, Inc. $DHI Purchased by PFA Pension ForsikringsaktieselskabMay 4 at 6:28 AM | marketbeat.comD.R. Horton, Inc. $DHI Shares Sold by Danske Bank A SMay 4 at 4:09 AM | marketbeat.comBaypointe Partners LLC Sells 40,782 Shares of D.R. Horton, Inc. $DHIMay 4 at 3:31 AM | marketbeat.comUS Bancorp DE Has $14.06 Million Position in D.R. Horton, Inc. $DHIMay 3, 2026 | marketbeat.comAnalysts Are Bullish on These Consumer Cyclical Stocks: DR Horton (DHI), Gildan Activewear (GIL)May 3, 2026 | theglobeandmail.comOppenheimer Asset Management Inc. Sells 11,079 Shares of D.R. Horton, Inc. $DHIMay 3, 2026 | marketbeat.comCitizens Jmp Has Bullish Outlook for D.R. Horton Q3 EarningsMay 1, 2026 | marketbeat.comQ3 EPS Estimates for D.R. Horton Increased by AnalystMay 1, 2026 | marketbeat.comWolfe Research Has Negative View of D.R. Horton Q3 EarningsMay 1, 2026 | marketbeat.comD.R. Horton Enters the New Home Market in Rochester, MinnesotaMay 1, 2026 | finance.yahoo.comMartin Marietta Q1 Earnings Miss Estimates, Revenues Beat, Stock UpApril 30, 2026 | finance.yahoo.comEMCOR Q1 Earnings and Revenues Beat Estimates, Both Rise Y/Y, Stock UpApril 29, 2026 | finance.yahoo.comD.R. Horton (DHI) Beats Annual Revenue Forecast EstimatesApril 29, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWith Nike Shares Near a 12-Year Low, Is Now the Time to Be Brave?By Sam Quirke | April 12, 20263 Dividend Aristocrats Whose Yields Can Help Combat InflationBy Chris Markoch | April 9, 2026Homebuilder Earnings: D.R. Horton Sticks Out as Pulte & NVR Sales TankBy Leo Miller | April 27, 2026This New ETF Aims to Capitalize on Surging AI Memory Chip DemandBy Jessica Mitacek | April 13, 20263 Homebuilder Stocks Signaling Opportunity in a High-Rate WorldBy Chris Markoch | April 17, 2026DHI, BCC, and DGX Company DescriptionsBoise Cascade NYSE:BCC$72.83 -1.41 (-1.90%) Closing price 03:59 PM EasternExtended Trading$72.81 -0.02 (-0.03%) As of 06:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Boise Cascade Company engages in manufacture of wood products and distribution of building materials in the United States and Canada. It operates through two segments, Wood Products and Building Materials Distribution. The Wood Products segment manufactures laminated veneer lumber and laminated beams used in headers and beams; I-joists for residential and commercial flooring and roofing systems, and other structural applications; structural, appearance, and industrial plywood panels; and ponderosa pine shop lumber and appearance grade boards. The Building Materials Distribution segment distributes a line of building materials, including oriented strand boards, plywood, and lumber; general line items, such as siding, composite decking, doors, metal products, insulation, and roofing; and engineered wood products. It markets and sells its products to dealers, home improvement centers, wholesalers, specialty distributors, and industrial converters for use in the construction of new residential housing, repair-and-remodeling of existing housing, construction of light industrial and commercial buildings, and other industrial applications. Boise Cascade Company was incorporated in 2004 and is headquartered in Boise, Idaho.Quest Diagnostics NYSE:DGX$190.84 +1.71 (+0.90%) Closing price 03:59 PM EasternExtended Trading$190.05 -0.79 (-0.41%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.D.R. Horton NYSE:DHI$146.11 -3.06 (-2.05%) Closing price 03:59 PM EasternExtended Trading$145.43 -0.68 (-0.47%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.D.R. Horton, Inc. operates as a homebuilding company in East, North, Southeast, South Central, Southwest, and Northwest regions in the United States. It engages in the acquisition and development of land; and construction and sale of residential homes in 118 markets across 33 states under the names of D.R. Horton, America's Builder, Express Homes, Emerald Homes, and Freedom Homes. The company constructs and sells single-family detached homes; and attached homes, such as townhomes, duplexes, and triplexes. It also provides mortgage financing services; and title insurance policies, and examination and closing services, as well as engages in the residential lot development business. In addition, the company develops, constructs, owns, leases, and sells multi-family and single-family rental properties; and owns non-residential real estate, including ranch land and improvements. It primarily serves homebuyers. D.R. Horton, Inc. was founded in 1978 and is headquartered in Arlington, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Why Lam Research Still Looks Like a Buy After a 300% Rally IonQ Just Posted a Breakout Quarter—But 1 Problem Remains Super Micro Surges Over 20% as Margins Soar, Sales Fall Short Nuts and Bolts AI Play Gains Momentum: Astera Labs Targets Raised Anheuser-Busch Stock Jumps as Volume Growth Signals Turnaround Light Speed Returns: Corning Cashes In on NVIDIA Growth Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
